|
| ||||||||||
|
|
|
|
|
|
|
||||
| ||||||||||
|
|
|
|
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Compendium of Animal Rabies Control, 1995 National Association of State Public Health Veterinarians, Inc. *The purpose of this Compendium is to provide rabies information to veterinarians, public health officials, and others concerned with rabies control. These recommendations serve as the basis for animal rabies-control programs throughout the United States and also facili- tate standardization of procedures among jurisdictions, thereby contributing to an effective national rabies-control program. This document is reviewed annually and revised as necessary. Recommenda- tions for immunization procedures are contained in Part I; all animal rabies vaccines licensed by the U.S. Department of Agriculture (USDA) and marketed in the United States are listed in Part II; Part III details the principles of rabies control. Part I: Recommendations for Immunization Procedures
All animal rabies vaccines should be restricted to use by, or under the direct supervision of, a veterinarian. B. Vaccine Selection In comprehensive rabies-control programs, only vaccines with a 3-year duration of immunity should be used. This procedure constitutes the most effective method of increasing the proportion of immunized dogs and cats in any population. (See Part II.) C. Route of Inoculation All vaccines must be administered in accordance with either the specifications of the product label or the package insert. If adminis- tered intramuscularly, vaccine must be administered at one site in the thigh. D. Wildlife Vaccination Parenteral vaccination of captive wildlife is not recommended because the efficacy of rabies vaccines in such animals has not been established and no vaccine is licensed for wildlife. For this reason and because virus-shedding periods are unknown, bats and wild or exotic carnivores should not be kept as pets. Zoos or research insti- tutions may establish vaccination programs that attempt to protect valuable animals, but these programs should not be in lieu of appro- priate public health activities that protect humans. The use of licensed oral vaccines for the mass immunization of wildlife should be considered in selected situations, with the approval of the state agency responsible for animal rabies control. E. Accidental Human Exposure to Vaccine Accidental inoculation may occur during administration of animal rabies vaccine. Such exposure to inactivated vaccines constitutes no risk for acquiring rabies. F. Identification of Vaccinated Animals All agencies and veterinarians should adopt the standard tag system. This practice will aid persons who administer local, state, national, and international rabies control procedures. Animal license tags should be distinguishable in shape and color from rabies tags. Anodized aluminum rabies tags should be no less than 0.064 inches in thickness.
Part II: Vaccines Marketed in the United States and NASPHV Recommenda- tions Table_1 Part III: Rabies Control
The public should be warned not to handle wildlife. Wild mammals (as well as the offspring of wild species cross-bred with domestic dogs and cats) that bite or otherwise expose humans, pets, or live- stock to rabies should be considered for euthanasia and rabies exami- nation. A person bitten by any wild mammal should immediately report the incident to a physician who can evaluate the need for antirabies treatment. ***
THE NASPHV COMMITTEE: Suzanne R. Jenkins, VMD, MPH, Chair; Keith A. Clark, DVM, PhD; John G. Debbie, MS, DVM; Russell J. Martin, DVM, MPH; Grayson B. Miller, Jr., MD; F. T. Satalowich, DVM, MSPH; Faye E. Sorhage, VMD, MPH. CONSULTANTS TO THE COMMITTEE: James E. Childs, ScD, (Centers for Disease Control and Prevention {CDC}); Robert B. Miller, DVM, MPH (APHIS, USDA); Patrick Morgan, DVM, DrPH (AVMA Council on Public Health and Regulatory Veterinary Medicine); Charles E. Rupprecht, VMD, PhD (CDC); R. Keith Sikes, DVM, MPH; Richard A. Zehr (Veterinary Biologics Section, Animal Health Institute). ENDORSED BY: American Veterinary Medical Association (AVMA); Council of State and Territorial Epidemiologists (CSTE). Address all correspondence to: Suzanne R. Jenkins, VMD, MPH, Office of Epidemiology, Virginia State Department of Health, P.O. Box 2448, Richmond, VA 23218. ** 42 CFR No. 71.51. *** Centers for Diesase Control and Prevention. Rabies Prevention -- United States, 1991. MMWR 1991;40(No. RR-3):1-19. Table_1 Note: To print large tables and graphs users may have to change their printer settings to landscape and use a small font size.
Table 1. Vaccines Marketed in the United States and NASPHV Recommendations
============================================================================================================================================
For use Dosage Age at Booster Route of
in (mL) primary recommended inoculation
Product name Produced by Marketed by vaccination *
--------------------------------------------------------------------------------------------------------------------------------------------
A) INACTIVATED
--------------------------------------------------------------------------------------------------------------------------------------------
TRIMUNE Fort Dodge Fort Dodge Dogs 1 3 mos & Triennially IM +
License No. 112 Cats 1 1 yr later Triennially IM
ANNUMUNE Fort Dodge Fort Dodge Dogs 1 3 mos Annually IM
License No. 112 Cats 1 3 mos Annually IM
DURA-RAB 1 ImmunoVet ImmunoVet, Vedco, Inc. Dogs 1 3 mos Annually IM
License No. 302-A Cats 1 3 mos Annually IM
DURA-RAB 3 ImmunoVet ImmunoVet, Vedco, Inc. Dogs 1 3 mos & Triennially IM
License No. 302-A Cats 1 1 yr later Triennially IM
RABCINE 3 ImmunoVet SmithKline Beecham Dogs 1 3 mos & Triennially IM
License No. 302- A Animal Health Cats 1 1 yr later Triennially IM
ENDURALL-K SmithKline Beecham SmithKline Beecham Dogs 1 3 mos Annually IM
License No. 189 Animal Health Cats 1 3 mos Annually IM
ENDURALL-P SmithKline Beecham SmithKline Beecham Dogs 1 3 mos Annually IM or SQ &
License No. 189 Animal Health Cats 1 3 mos Annually SQ
RABGUARD-TC SmithKline Beecham SmithKline Beecham Dogs 1 3 mos & Triennially IM
License No. 189 Animal Health Cats 1 1 yr later Triennially IM
Sheep 1 3 mos Annually IM
Cattle 1 3 mos Annually IM
Horses 1 3 mos Annually IM
DEFENSOR SmithKline Beecham SmithKline Beecham Dogs 1 3 mos & Triennially IM or SQ
License No. 189 Animal Health Cats 1 1 yr later Triennially SQ
Sheep 2 3 mos Annually IM
Cattle 2 3 mos Annually IM
RABDOMUN SmithKline Beecham Mallinckrodt Veterinary, Dogs 1 3 mos & Triennially IM or SQ
License No. 189 Inc. Cats 1 1 yr later Triennially SQ
Sheep 2 3 mos Annually IM
Cattle 2 3 mos Annually IM
RABDOMUN-1 SmithKline Beecham Mallinckrodt Veterinary, Dogs 1 3 mos Annually IM or SQ
License No. 189 Inc. Cats 1 3 mos Annually SQ
SENTRYRAB 1 SmithKline Beecham Synbiotics Corp. Dogs 1 3 mos Annually IM
License No. 225 Cats 1 3 mos Annually IM
CYTORAB Coopers Animal Health, Coopers Animal Health, Dogs 1 3 mos Annually IM
Inc., License No. 107 Inc. Cats 1 3 mos Annually IM
TRIRAB Coopers Animal Health, Coopers Animal Health, Dogs 1 3 mos & Triennially IM
Inc., License No. 107 Inc. 1 yr later
Cats 1 3 mos Annually IM
EPIRAB Coopers Animal Health, Coopers Animal Health, Dogs 1 3 mos & Triennially IM
Inc., License No. 107 Inc. Cats 1 1 yr later Triennially IM
RABVAC 1 Solvay Animal Health, Solvay Animal Health, Dogs 1 3 mos Annually IM or SQ
Inc., License No. 195-A Inc. Cats 1 3 mos Annually IM or SQ
RABVAC 3 Solvay Animal Health, Solvay Animal Health, Dogs 1 3 mos & Triennially IM or SQ
Inc., License No. 195-A Inc. Cats 1 1 yr later Triennially IM or SQ
Horses 2 3 mos Annually IM
PRORAB 1 Intervet, Inc. Intervet, Inc. Dogs 1 3 mos Annually IM or SQ
License No. 286 Cats 1 3 mos Annually IM or SQ
Sheep 2 3 mos Annually IM
RM IMRAB 1 Rhone Merieux, Inc. Rhone Merieux, Inc. Dogs 1 3 mos Annually IM or SQ
License No. 298 Cats 1 3 mos Annually IM or SQ
RM IMRAB BOVINE Rhone Merieux, Inc. Rhone Merieux, Inc. Cattle 2 3 mos Annually IM or SQ
PLUS License No. 298 Horses 2 3 mos Annually IM or SQ
Sheep 2 3 mos Triennially IM or SQ
RM IMRAB 3 Rhone Merieux, Inc. Rhone Merieux, Inc. Dogs 1 3 mos & Triennially IM or SQ
License No. 298 Cats 1 1 yr later Triennially IM or SQ
Sheep 2 3 mos & Triennially IM or SQ
1 yr later
Cattle 2 3 mos Annually IM or SQ
Horses 2 3 mos Annually IM or SQ
Ferrets 1 3 mos Annually SQ
--------------------------------------------------------------------------------------------------------------------------------------------
B) COMBINATION (inactivated rabies)
--------------------------------------------------------------------------------------------------------------------------------------------
ECLIPSE 3 KP-R Solvay Animal Health, Solvay Animal Health, Cats 1 3 mos Annually IM
Inc., License No. 195-A Inc.
ECLIPSE 4 KP-R Solvay Animal Health, Solvay Animal Health, Cats 1 3 mos Annually IM
Inc., License No. 195-A Inc.
CYTORAB RCP Coopers Animal Health, Coopers Animal Health, Cats 1 3 mos Annually IM
Inc., License No. 107 Inc.
FEL-O-VAX Fort Dodge Fort Dodge Cats 1 3 mos & Triennially IM
PCT-R License No. 112 1 yr later
RM FELINE 4 + Rhone Merieux, Inc. Rhone Merieux, Inc. Cats 1 3 mos & Triennially SQ
IMRAB 3 License No. 298 1 yr later
RM FELINE 3 + Rhone Merieux, Inc. Rhone Merieux, Inc. Cats 1 3 mos & Triennially SQ
IMRAB 3 License No. 298 1 yr later
RM EQUINE Rhone Merieux, Inc. Rhone Merieux, Inc. Horses 1 3 mos Annually IM
POTOMAVAC License No. 298
+ IMRAB
--------------------------------------------------------------------------------------------------------------------------------------------
* >= 3 months of age and revaccinated 1 year later.
+ Intramuscularly.
& Subcutaneously.
============================================================================================================================================
Return to top. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|